http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113209063-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-74 |
| filingDate | 2021-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113209063-B |
| titleOfInvention | Application of tiger aldehyde in preparation of medicament for treating ovarian cancer |
| abstract | The invention relates to the application of tiger aldehyde in the preparation of drugs for treating ovarian cancer. The invention finds that tiger aldehyde can effectively kill ovarian cancer cell line SKVO3 cells, and promote the apoptosis of SKVO3 cells by enhancing cell autophagy and autophagy flow. , inhibits the migration of SKVO3 cells, has obvious anti-ovarian cancer activity, and can be developed into a drug for the treatment of ovarian cancer. The present invention provides an important theoretical basis for the treatment of ovarian cancer with tiger aldehyde, broadens the therapeutic range of the drug, and simultaneously provides a new drug solution for improving the treatment level of the existing ovarian cancer and improving the prognosis. |
| priorityDate | 2021-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2948 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419510938 |
Total number of triples: 16.